Quotes

Back To Menu

Tata India Pharma & Healthcare Fund (IDCW) RI Equity - Pharma
INVEST

Plan: OPEN | Option: Dividend | Rajat Srivastava

17 Dec 25 | 12:00 AM

29.99 -0.26 (-0.86%)

  • Underperforms

    -1.49%

    Return (1Y)

    underperformed BSE Healthcare TRI by -49.80%

  • More Volatile

    0.91%

    Standard Deviation (1Y)

    Higher Equity - Pharma by 0.91%

  • Inconsistent

    /0

    Months

    Has underperformed Equity - Pharma

  • Value research rating

    Not Rated

Stock Composition

NAV

Critical Parameters

Everyone of us wants to create wealth by investing in top funds. Have a look at the key parameters that you need to check before deciding to invest in a mutual fund.

Returns

In last 1 year Tata India Pharma & Healthcare Fund (IDCW) RI, has underperformed by -49.80% (CAGR difference)

-1.49%

Underperforms

This is Alpha

Performance Chart for Rs

Invested in

18 Dec 2024

Risk

In last 1 year , the volatility of Tata India Pharma & Healthcare Fund (IDCW) RI is Higher than by 0.91%

0.91%

More Volatile

Risk Meter

Peer Comparison on Risk - Return

Consistency

For out of Last 0 Months, i.e 0% of the times It underperformed its benchmark, Equity - Pharma

Consistency Meter

Outperforming Stocks Vs. Underperforming Stocks

Based on the last 1year analysis, currently there are, the benchmark the benchmark

View Stock Composition